Evaluation of Preptin and other Biomarkers in Coronary Artery Disease Patients with and without Diabetes Mellitus
Background: Preptin is an endocrine peptide with 34 amino acids. Conjugated with insulin, it is produced by β-cells from the pro-insulin-like growth factor 2 E-peptide. However, in addition to insulin, pancreatic hormone (Preptin) is released in response to elevated blood glucose levels. Preprint’s...
Saved in:
Main Authors: | Saja T. Yassen, Layla O. Farhan |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Medicine University of Baghdad
2024-12-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/2350 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determination of Irisin, Body Mass Index, and Other Biochemical Parameters in a Sample of Iraqi Type II Diabetic Patients
by: Takwa Al Koloob Ali Chachan, et al.
Published: (2022-09-01) -
Relationship between uric acid to HDL ratio and extent and severity of coronary artery disease
by: Mehmet Yaman, et al.
Published: (2024-11-01) -
Osteopontin as a Biomarker for Coronary Artery Disease
by: Georgia R. Layton, et al.
Published: (2025-01-01) -
Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent
by: Juan Wang, et al.
Published: (2025-01-01) -
Multivessel Coronary Artery Disease in Diabetes Mellitus Patients
by: Amanj Kamal Mohammed
Published: (2019-11-01)